Found 205 Type 2 Diabetes Mellitus trials
A listing of Type 2 Diabetes Mellitus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The purpose of this study is to see whether a drug called naltrexone improves health-related quality of life in patients with vasculitis. Naltrexone is a prescription drug approved for a different reason at a higher dose than the dose used in this study. However, “low dose naltrexone” is widely used, …
The main purpose of this study is to understand how patients with giant cell arteritis (GCA) respond to an investigational drug called abatacept (also called Orencia). Abatacept is being tested to determine if it is effective in treating GCA. An investigational drug is one that is not approved by the …
Approximately 50% of patients with celiac disease have continued symptoms despite at least 12 months of treatment with a gluten free diet. PRV-015, a mAb that blocks IL-15, has been shown to reduce intestinal inflammation and improve clinical symptoms induced by gluten consumption in a previous Phase 2a gluten-challenge study …
The goal of study 1 and study 2 is to evaluate the effects of ALN-HSD on liver fibrosis and other histologic features of NASH in participants with NASH and F2/F3 fibrosis and risk alleles for HSD17B13. Necessary screening procedures include blood tests, liver stiffness measurement, study-specific genotype criteria, and a …
The aim of this global Phase III study is to investigate the use of tezepelumab as a treatmentfor patients with EoE. This study will evaluate the efficacy and safety of tezepelumab 210 mgevery 4 weeks (Q4W) and tezepelumab 420 mg Q4W administered subcutaneously (SC) usingan accessorized pre-filled syringe (APFS) versus …
Study M21-446 is a Phase 2a, multicenter, open label proof of concept study to investigate the efficacy and safety of ABBV-668 in subjects with moderate to severe UC. The study contains a 30-day screening period, 16-week treatment period, and a 30-day follow up period from the last dose of study …
The primary objective of this study is to evaluate the safety and efficacy of the ProTractX3 DCB for the treatment of benign esophageal strictures. The ProTractX3 DCB is intended to treat benign strictures of the alimentary tract, combining mechanical dilation with localized delivery of the drug paclitaxel. The ProTractX3 DCB …
The primary objective is to determine the safety and efficacy of GIE Medicals ProTractX3 TTS DCB for the treatment of recurrent benign bowel strictures. The ProTractX3 DCB is intended to treat benign strictures of the alimentary tract, combining mechanical dilation with localized delivery of the drug paclitaxel. The goal of …
The purpose of this study is to better understand molecular pathways and joint destruction in patients with autoimmune diseases such as Psoriatic Arthritis (PsA).
